Elevated levels of the BACE1-antisense transcript alongside dysregulated miR-485-5p levels in AD patients implicating increased stability of the BACE1 transcript by preventing interaction between miR-485-5p and its seed sequence [69]. Here, BACE1 is linked to Alzheimer disease.